Category: Featured

Stressed Wall Street Execs Flock to Ketamine Therapy Sessions (NY Post)

Therapy’s a trip for these Wall Street executives. Wealthy stock traders are flocking to a Manhattan-based ketamine therapy practice that doles out the hallucinogenic drug in a lavish setting to...

Silo Pharma (SILO) Attends Dawson James Conference.

We watched an excellent presentation from management at the Dawson conference and starting our due diligence now. Primary item of our interest is a joint...

‘Magic Mushroom’ Psychedelic may Help Heavy Drinkers Quit (AP News)

Psychedelic Drug Helped People with Alcohol use Disorder Reduce Drinking, Study Shows (Today) Psilocybin, the ingredient in magic mushrooms, along with talk...

Stan Grof, Psychedelic’s Elder Statesman.

Stan Grof — Lessons from ~4,500 LSD Sessions and Beyond https://youtu.be/3mdYUmvTeig PLAYLIST Start How did Stan first...

PharmaTher (PHRM, PHRRF) $0.10 Gets $3.80 Price Target From H.C. Wainwright – 37 Times (3,700%) Higher.

Thus, to us, the key potential positive events that could lead to a rerating in PHRM.CN shares include publication of the Phase 2 trial data evaluating ketamine in LID-PD in...

Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.

MIAMI, June 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will accept delivery of...

Australian Icannex (IHL:ASX) Headed to NASDAQ?

Incannex completes Phase 2 trial for its cannabinoid drug for sleep apnea, flags Nasdaq listing in 2022 With Phase 2 dosing complete,...

Testimonial: The Ibogaine Clinic, Playa Del Carmen

VIDEO TESTIMONIALS https://youtu.be/hrrLoxuR2oo VISIT WEBSITE
Most Popular

Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.

Partnered with ATAI Life Sciences ATAI. Amazing Interview. "I said there's no way that you can take one dose of Ibogaine...

Psychedelic Marketing: Adrian Morrison

https://youtu.be/EZPAoTFqaro

Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes

Mike Zapolin, Kevein Harrington and CEO Chad Harman Another Shark Tank original has invested in the psychedelic industry.